Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 199.00
Bid: 202.00
Ask: 204.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.99%)
Open: 202.00
High: 203.00
Low: 199.00
Prev. Close: 199.00
JHD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Statement

25 Jul 2018 07:00

RNS Number : 6057V
James Halstead PLC
25 July 2018
 

25 July 2018

 

 

Pre-Close Trading Statement

 

 

James Halstead plc, the commercial flooring manufacturer and distributor, is providing the following trading update ahead of its final results for the year ended 30 June 2018.

 

We are pleased to report that sales for the year were ahead of the comparative year. This represents a creditable performance in still difficult trading conditions. It is particularly pleasing to report that our UK turnover is 3% ahead of the prior year in a market that seems to be quite robust despite the well reported spending cuts and high street retailer issues.

 

In the Chairman's interim statement, announced on 29 March 2018, it was noted that adverse price pressure on raw materials was holding back the benefits of export currency gains. This continued in the second half year but was ameliorated by increased sales. The Chairman, in that statement, noted that a German competitor had entered administration and at that time we decided to undertake our largest ever re-vamp of our homogenous flooring ranges with the launch of "Palettone."

 

Palettone is a premium homogenous sheet vinyl collection, launched in May 2018. It is the largest new product development by any manufacturer in this core product area in many years. It offers a collection of 50 colours optimised for our global market and is presented in a unique, innovative sample package with full customer support from specification to installation. The feedback we have received on the collection since launch has been exceptional.

 

The costs of development trials, sampling, marketing material and related costs have been around £2 million and the product has just been launched into the global market place. The timescale that our production and marketing staff worked to was ambitious and we are delighted with the successful launch.

 

In line with best practice, we shall expense these costs rather than amortise or construct an adjustment to "underlying" earnings.

 

Consequently we are pleased to anticipate, once again, reporting record turnover and expect profits for the year to 30 June 2018 will be in line with last year.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. 

 

 

Enquiries:

 

 

Mark Halstead, Chief Executive

 

Gordon Oliver, Finance Director

Telephone: 0161 767 2500

 

 

Nick Lyon - Hudson Sandler

Telephone: 020 7796 4133

 

 

Ben Thorne

Dominic Morley - Panmure Gordon

(Nominated advisor and broker)

 

Telephone: 020 7886 2500

 

Chris Hardie - Arden Partners

Telephone: 020 7614 5900

(Broker)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBZLFLVDFEBBX
Date   Source Headline
1st Feb 201311:15 amRNSNotice of Interim Results Date Change
31st Jan 20134:00 pmRNSTotal Voting Rights
31st Jan 20137:00 amRNSPre-close Trading Statement
10th Jan 201311:00 amRNSIssue of Equity and Total Voting Rights
7th Jan 20139:00 amRNSBlocklisting Interim Review
11th Dec 20127:00 amRNSBonus Issue
7th Dec 20124:40 pmRNSSecond Price Monitoring Extn
7th Dec 20124:35 pmRNSPrice Monitoring Extension
7th Dec 20127:00 amRNSAGM Statement
3rd Dec 20127:00 amRNSTotal Voting Rights
1st Nov 20127:00 amRNSTotal Voting Rights
23rd Oct 20127:00 amRNSAnnual Financial Report
1st Oct 20127:00 amRNSPreliminary Audited Results
3rd Sep 20127:00 amRNSTotal Voting Rights
30th Jul 20127:00 amRNSPre-close Trading Statement
2nd Jul 20129:00 amRNSBlocklisting Interim Review
6th Jun 20124:40 pmRNSSecond Price Monitoring Extn
6th Jun 20124:35 pmRNSPrice Monitoring Extension
1st Jun 20127:00 amRNSTotal Voting Rights
25th May 20122:00 pmRNSDirector/PDMR Shareholding
1st May 20127:00 amRNSTotal Voting Rights
2nd Apr 20123:45 pmRNSDirector/PDMR Shareholding
29th Mar 20127:00 amRNSInterim Results
12th Mar 20124:35 pmRNSPrice Monitoring Extension
1st Mar 20127:00 amRNSTotal Voting Rights
30th Jan 20127:00 amRNSPre-Close Trading Statement
11th Jan 20127:00 amRNSAppointment of Broker
4th Jan 20127:00 amRNSAppointment of non-executive director
3rd Jan 20127:00 amRNSBlocklisting Interim Review
3rd Jan 20127:00 amRNSTotal Voting Rights
6th Dec 20111:00 pmRNSDirector's shareholding
5th Dec 20114:45 pmRNSChange in shareholdings
2nd Dec 20117:00 amRNSAGM Statement
30th Nov 201110:50 amRNSResult of Tender Offer
14th Nov 20117:00 amRNSTender Offer and Trading Update
1st Nov 20117:00 amRNSTotal Voting Rights
28th Oct 20112:00 pmRNSAnnual Financial Report
11th Oct 201111:00 amRNSChange in Director's Holding
3rd Oct 20117:00 amRNSPreliminary Results
6th Sep 20117:00 amRNSNotice of Results
15th Aug 20117:00 amRNSTotal Voting Rights
26th Jul 20117:00 amRNSPre-close Trading Statement
6th Jul 20118:45 amRNSDirector/PDMR Shareholding
1st Jul 20117:00 amRNSBlocklisting Interim Review
3rd May 20117:00 amRNSTotal Voting Rights
15th Apr 20112:40 pmRNSDirector/PDMR Shareholding
1st Apr 20117:00 amRNSTotal Voting Rights
31st Mar 20117:00 amRNSInterim Results
31st Jan 20112:00 pmRNSHolding(s) in Company
31st Jan 20117:00 amRNSPre-close Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.